Loading...
Market
Which category will be Huma Therapeutics' most successful application in 2024?
2
Resolution / Starting Odds
Chronic Disease Management • 25%
Mental Health • 25%
Telemedicine • 25%
Other • 25%
Official usage statistics or revenue reports from Huma Therapeutics
Story
Huma Therapeutics Raises $80M in Series D, Near-$1B Valuation
Jul 16, 2024, 11:02 AM
Huma Therapeutics, a London-based healthcare startup, has successfully raised $80 million in a Series D funding round, bringing its total funding to $300 million and valuing the company at nearly $1 billion. The funding round saw participation from notable investors including AstraZeneca, Hat Technology Fund 4 by HAT SGR, HV Fund by Hitachi Ventures, and Leaps by Bayer. Huma uses AI to help developers create health applications and aims to turn text into healthcare apps using generative AI. The startup is often referred to as the 'Shopify of digital health' and its underlying models can develop a healthcare application prototype in minutes with just a simple user prompt.
View original story
Similar markets
Cancer drugs • 25%
COVID-19 treatment • 25%
Vaccines • 25%
Other pharmaceuticals • 25%
Drug Development • 25%
Disease Diagnosis • 25%
Biosensor Technology • 25%
Other • 25%
Afami-cel • 25%
Cosibelimab • 25%
Adagrasib-Cetuximab • 25%
Other • 25%
Cancer • 25%
Neurological disorders • 25%
Infectious diseases • 25%
Other • 25%
Cancer • 25%
Cardiovascular diseases • 25%
Neurological disorders • 25%
Other • 25%
Breast Cancer Diagnosis • 25%
Lung Cancer Diagnosis • 25%
Prostate Cancer Diagnosis • 25%
Other • 25%
Military • 25%
Civilian Emergency Services • 25%
Both • 25%
Neither • 25%
Medical Devices • 25%
Robotics • 25%
Consumer Electronics • 25%
Other • 25%
Hospitals • 25%
Clinics • 25%
Telehealth Services • 25%
Insurance Companies • 25%
Cosmetics • 25%
Medical treatments • 25%
Robotics • 25%
Other • 25%
AI-powered document search tool • 25%
AI-driven data analytics platform • 25%
AI-based customer service solution • 25%
Other • 25%
Diagnosis • 25%
Prescribing • 25%
Vaccine scheduling • 25%
Prescription fulfillment • 25%